Dependent variable | Model | Independent variables | B estimate (95% CI) | Standardized β | P valueb |
---|---|---|---|---|---|
Hippocampal volume | I-1 | Age | − 23.01 (− 28.71~ − 17.30) | − 0.414 | < 0.001** |
Gender | 96.58 (− 9.99~203.15) | 0.099 | 0.076 | ||
Educational level | − 3.93 (− 15.21~7.35) | − 0.038 | 0.494 | ||
APOEε4 | − 174.78 (− 331.62~ − 17.93) | − 0.114 | 0.029* | ||
Dyslipidemia | 167.05 (58.20~275.89) | 0.159 | 0.003** | ||
Hippocampal volume | I-2 | Age | − 22.67 (− 28.45~ − 16.88) | − 0.408 | < 0.001** |
Gender | 89.25 (−17.90~196.40) | 0.091 | 0.102 | ||
Educational level | − 1.97 (− 13.24~9.29) | − 0.019 | 0.731 | ||
APOEε4 | − 158.91 (− 316.83~ − 1.00) | − 0.104 | 0.049* | ||
Dyslipidemia: Group 3a | 90.55 (9.06~172.04) | 0.116 | 0.030* | ||
White matter hyperintensity | II | Age | 0.024 (0.017~0.032) | 0.345 | < 0.001** |
Gender | − 0.129 (− 0.268~0.010) | − 0.104 | 0.068 | ||
Educational level | − 0.004 (− 0.019~0.011) | − 0.030 | 0.601 | ||
APOEε4 | 0.094 (−0.111~0.299) | 0.048 | 0.4368 | ||
Hypertension | 0.174 (0.040~0.309) | 0.139 | 0.011* | ||
Statin therapy | − 0.236 (− 0.386~ − 0.086) | − 0.167 | 0.002** |